Consideration of Costs and Open-Label Studies of Erenumab-Reply.
Saved in:
| Title: | Consideration of Costs and Open-Label Studies of Erenumab-Reply. |
|---|---|
| Authors: | Loder EW; Division of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Burch RC; Division of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. |
| Source: | JAMA neurology [JAMA Neurol] 2019 Feb 01; Vol. 76 (2), pp. 236-237. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6157 |
|---|---|
| DOI: | 10.1001/jamaneurol.2018.4141 |